Researchers have widely criticised a new study that questions the safety of water fluoridation, arguing the findings were overstated and the study poorly designed.
Feb 25, 2015
4
51
Pregnant women in Austria commonly suffer from an iodine deficiency. This may have a negative impact on the development of their unborn child's brain. These are the key findings of a joint study by the Endocrinology and Metabolism ...
Jan 20, 2015
0
90
For the first time, researchers have found that exposure to radioactive iodine is associated with more aggressive forms of thyroid cancer, according to a careful study of nearly 12,000 people in Belarus who were exposed when ...
Oct 28, 2014
0
1
Cystoid macular edema (CME) is a common complication of retinitis pigmentosa (RP), a family of retinal diseases in which patients typically lose night and side vision first and then develop impaired central vision. CME can ...
Jul 21, 2014
0
0
(Medical Xpress)—Including seaweed in the diet could help reduce iodine insufficiency, a current problem in the UK population, according to a new study.
Jul 18, 2014
0
0
(HealthDay)—Many pregnant and breast-feeding women are deficient in iodine and should take a daily supplement containing iodide, according to a leading group of pediatricians.
May 26, 2014
0
0
(Medical Xpress)—The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to a new study from researchers in the Abramson Cancer Center at the University ...
Apr 25, 2014
0
0
Scientists have discovered a potential cure for one of the most aggressive and least treatable forms of breast cancer called "triple negative breast cancer." In laboratory experiments involving human cancer cells, scientists ...
Jan 30, 2014
0
0
Iodine is essential for the human body. This trace element is especially crucial for infants in order to ensure healthy development. Iodine deficiency can disrupt growth and damage the nervous system. In iodine-poor regions, ...
Nov 25, 2013
0
0
(HealthDay)—U.S. Food and Drug Administration approval for the anti-cancer drug Nexavar (sorafenib) has been expanded to include late-stage differentiated thyroid cancer, the most common type of thyroid cancer.
Nov 24, 2013
0
0
